Clinical Trial Update: Selinexor (KPT-330) in Combination With Temozolomide and Radiation Therapy in Patients With Newly Diagnosed Glioblastoma [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating selinexor in combination with temozolomide and radiation therapy for newly diagnosed glioblastoma (and gliosarcoma) with results posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma
• Gliosarcoma

Drugs mentioned

• Selinexor (selinexor)
• Temodar (Temozolomide)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Gliosarcoma, Newly Diagnosed | Phase 1 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2024-10-15